| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/06/2008 | EP1951702A2 Diuretic-like compound analogs useful for regulation of central nervous system disorders |
| 08/06/2008 | EP1951692A1 Oxazole and thiazole ppar modulator |
| 08/06/2008 | EP1951689A1 P2x7 receptor antagonists and methods of use |
| 08/06/2008 | EP1951687A1 N-hydroxyamide derivatives and use thereof |
| 08/06/2008 | EP1951682A1 Novel 2-aminopyrimidinone or 2-aminopyridinone derivatives and their use |
| 08/06/2008 | EP1951681A1 Novel 2-aminopyrimidine derivatives and their use |
| 08/06/2008 | EP1951680A1 Novel 2-aminopyrimidinone derivatives and their use |
| 08/06/2008 | EP1951678A1 Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity |
| 08/06/2008 | EP1951656A1 Histone deacetylase inhibitors as therapeutics for neurological diseases |
| 08/06/2008 | EP1951653A1 Salicylic acid derivatives |
| 08/06/2008 | EP1951643A1 Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity |
| 08/06/2008 | EP1951308A1 Combination preparations containing physiological cell membrane constituents including phosphatidylserine, choline and a pyrimidine nucleoside/nucleotide |
| 08/06/2008 | EP1951291A1 Methods of regulating renalase (monoamine oxidase c) |
| 08/06/2008 | EP1951256A1 Quetiapine in a controlled release formulation |
| 08/06/2008 | EP1951247A2 Methods of treating nervous disorders |
| 08/06/2008 | EP1951238A2 Method for treating chronic pain |
| 08/06/2008 | EP1951228A2 Bicyclic spirohydantoin cgrp receptor antagonists |
| 08/06/2008 | EP1951051A2 Spirohydantoin tricyclic cgrp receptor antagonists |
| 08/06/2008 | EP1951042A2 Spirolactam tricyclic cgrp receptor antagonists |
| 08/06/2008 | EP1673371B1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 08/06/2008 | EP1651621B1 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators |
| 08/06/2008 | EP1648882B1 3-fluoro-piperidines as nmda/nr2b antagonists |
| 08/06/2008 | EP1641455B1 Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors |
| 08/06/2008 | EP1485088B1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
| 08/06/2008 | EP1476149B1 Substituted hydrazones as inhibitors of cyclooxygenase-2 |
| 08/06/2008 | EP1404641B1 Crystalline form of a phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same |
| 08/06/2008 | EP1385523B1 Adenosine a1 receptor antagonists for treating hypoxia-induced learning and memory impairment |
| 08/06/2008 | EP1385518B1 Benzimidazolone compounds |
| 08/06/2008 | EP1385515B1 Spiropyrazole compounds |
| 08/06/2008 | EP1379627B1 Method for differentiating mesenchymal stem cells into neural cells |
| 08/06/2008 | EP1328515B1 Indoline derivatives and their use as 5-ht2 receptor ligands |
| 08/06/2008 | EP1257298B1 Cosmid dna constructs and methods of making and using the same |
| 08/06/2008 | EP1237575B1 Tnf-alpha antagonist and lfa-1 antagonist for treating rheumatoid arthritis |
| 08/06/2008 | EP1133284B2 A process for the preparation of crystalline particles |
| 08/06/2008 | CN101238125A Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 08/06/2008 | CN101238124A Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 08/06/2008 | CN101238121A Fused bicycloheterocycle substituted quinuclidine derivatives |
| 08/06/2008 | CN101238117A Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 08/06/2008 | CN101238111A Cyclic ketal beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 08/06/2008 | CN101238106A Fluoro substituted 2-oxo azepan derivatives |
| 08/06/2008 | CN101238105A Aripiprazole salts |
| 08/06/2008 | CN101237885A Agent for regeneration and/or protection of nerves |
| 08/06/2008 | CN101237878A Intralesional treatment of psoriasis |
| 08/06/2008 | CN101237875A Pharmaceutical compositions comprising a tungsten salt (VI) for the treatment of neurodegenerative disorders, particularly alzheimer's disease and schizophrenia |
| 08/06/2008 | CN101237866A Use of thiazole derivatives and analogues in the treatment of cancer |
| 08/06/2008 | CN101237865A Methods of treatment utilizing certain melatonin derivatives |
| 08/06/2008 | CN101235057A Aminoglucose unsaturated fatty acid salt and application of the same in preparing medicament for curing nerve immunity incretion disease |
| 08/06/2008 | CN101235016A Method for synthesizing fat-reducing medicament rimonabant |
| 08/06/2008 | CN101234188A Pharmaceutical composition for treating pain and preparation thereof |
| 08/06/2008 | CN101234186A Decocting soup agent and hot drink cake preparation for treating aged kidney asthenia, frequent micturition and etc. diseases |
| 08/06/2008 | CN101234149A Composition for treating pain of head, face and limbs and various tendons clonic convulsion and preparation thereof |
| 08/06/2008 | CN101234121A Application of purslane amide alkaloid in preparing antioxidant and neuroprotective agent |
| 08/06/2008 | CN101234120A Notoginseng dropping pills and preparation method thereof |
| 08/06/2008 | CN101234111A Pharmaceutical composition containing memantine hydrochloride and huperzine A and preparation thereof |
| 08/06/2008 | CN101234104A Pharmaceutical composition containing lipoic acid and mecobalamin and preparation thereof |
| 08/06/2008 | CN100408677C Method for genetically modifying and inducing intracerebral transplantation mesenchymal stem cells to be differentitated into neuron |
| 08/06/2008 | CN100408577C Process for the preparation of imidazo(1,2-A)pyridine-3-acetamides |
| 08/06/2008 | CN100408575C Aryl-8-azabicyclo[3,2,1]octanes for treating depression |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408572C Imidazole derivatives as glutmate receptor antagonists |
| 08/06/2008 | CN100408570C EP4 receptor antagonists |
| 08/06/2008 | CN100408561C 2,3'-bipyridines derivatives as selective cox-2 inhibitors |
| 08/06/2008 | CN100408092C Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
| 08/06/2008 | CN100408080C Heart quieting and orifice opening capsule and its preparation |
| 08/06/2008 | CN100408068C Formula of tea dispelling the effects of alcohol and preparation method |
| 08/06/2008 | CN100408038C Use of a vitamin combination for the treatment of primary headaches |
| 08/05/2008 | US7408064 Neuropeptide y5 antagonist; therapy for eating disorders |
| 08/05/2008 | US7408036 Human voltage gated sodium channel β1A subunit and methods of use |
| 08/05/2008 | US7407990 Therapeutic Agents |
| 08/05/2008 | US7407986 Administering a isothiocyanate, such as sulforaphane, or a glucosinolate; retinal degeneration, Alzheimer's Disease, and aging |
| 08/05/2008 | US7407981 e.g., N-butyl-6-chloro-5-phenyl-1H-indazol-3-amine; kinase inhibitor; obesity and stroke; diseases involving phosphorylation of the tau protein such as Alzheimer's disease, Parkinson's disease, frontoparietal dementia |
| 08/05/2008 | US7407980 Therapeutic agents for treating central nervous system disorders, incotinence, sexual disorders, NASAL CONGESTION; ALPHA 1 ADRENERGIC AGONISTS; N-[4-(4,5-Dihydro-1H-imidazol-2-ylmethyl)-phenyl]-methanesulfonamide; chemical synthesis by cyclization |
| 08/05/2008 | US7407971 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 08/05/2008 | US7407970 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/05/2008 | US7407968 Compounds |
| 08/05/2008 | US7407964 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 08/05/2008 | US7407962 Heteroaryl compounds useful as inhibitors or protein kinases |
| 08/05/2008 | US7407954 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 08/05/2008 | US7407952 substance P, integrin receptor antagonist; mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins; antiinflammatory agent; cell adhesion-mediated disease and central nervous system disorders |
| 08/05/2008 | US7407939 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics |
| 08/05/2008 | US7407936 Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy |
| 08/05/2008 | US7407934 Controlling blood glucose concentration; amylin antagonist such as 25,28,29Pro-h-amylin, pramlintide; reducing gastric motility and delaying gastric emptying |
| 08/05/2008 | US7407933 Containing a mutant angiotensin-converting enzyme that releases glycosylphosphatidylinositol-anchored protein from cell surfaces; for treating a prion-related disease, a bacterial infectious disease or male infertility due to sperm-egg binding insufficiency |
| 08/05/2008 | US7407766 Screening method for agonists or antagonists of semaphorin 6C by determining the effect of a test compound on the interaction between semaphorin 6C and plexin-A1 |
| 08/05/2008 | US7407669 film delivers at least one oral care agent, such as antimicrobial agents and salivary stimulants |
| 08/05/2008 | CA2423820C New indoline derivatives, the process for preparing them and the pharmaceutical compounds that contain them |
| 08/05/2008 | CA2417081C New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 08/05/2008 | CA2390787C Combination of riluzole and gabapentin and use thereof as medicine |
| 08/05/2008 | CA2388476C Bicyclic imidazo-5-yl-amine derivatives |
| 08/05/2008 | CA2388470C Use of carbonylamino derivatives against cns disorders |
| 08/05/2008 | CA2353808C Agent for lowering endothelin levels |
| 08/05/2008 | CA2326502C Effervescent formulations |
| 08/05/2008 | CA2290622C Selective thyroid hormone analogs |
| 08/05/2008 | CA2279319C Benzofurazan compounds which enhance ampa receptor activity |
| 08/05/2008 | CA2268450C Neurotrophin antagonist compositions |
| 08/05/2008 | CA2259640C Human glycine transporter |
| 08/05/2008 | CA2161808C Bmp-11 compositions |
| 07/31/2008 | WO2008092091A2 Mao inhibiting n-benzyl-n-propargyl-amines useful for treating obesity |
| 07/31/2008 | WO2008092072A2 Modulators of the metabotropic glutamate receptor subtype 5 and uses thereof |
| 07/31/2008 | WO2008091901A1 Heterodimers and methods of using them |